RENAISSANCERE HOLDINGS LTD's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), RENAISSANCERE HOLDINGS LTD reported revenue of $12.8B (+9.9% year on year) and net income of $3.6B (+22.2% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Gross premiums written (Note 7) | $11.7B | $11.7B | $8.9B | $9.2B |
| Net premiums written (Note 7) | $9.9B | $10.0B | $7.5B | $7.2B |
| Decrease (increase) in unearned premiums | $31.0M | $143.5M | $3.3M | ($862.2M) |
| Net premiums earned (Note 7) | $9.9B | $10.1B | $7.5B | $6.3B |
| Net investment income (Note 5) | $1.7B | $1.7B | $1.3B | $559.9M |
| Net foreign exchange gains (losses) | ($13.5M) | ($76.1M) | ($41.5M) | ($56.9M) |
| Equity in earnings (losses) of other ventures (Note 5) | $71.3M | $47.1M | $43.5M | $11.2M |
| Other income (loss) | $4.3M | $1.9M | ($6.2M) | $12.6M |
| Net realized and unrealized gains (losses) on investments | $1.2B | ($27.8M) | $414.5M | ($1.8B) |
| Total revenues | $12.8B | $11.7B | $9.1B | $5.1B |
| Net claims and claim expenses incurred (Notes 7 and 8) | $5.6B | $5.3B | $3.6B | $4.3B |
| Acquisition expenses | $2.6B | $2.6B | $1.9B | $1.6B |
| Operational expenses | $464.5M | $496.6M | $375.2M | $276.7M |
| Corporate expenses | $82.0M | $134.8M | $127.6M | $46.8M |
| Interest expense (Note 9) | $120.9M | $93.8M | $73.2M | — |
| Total expenses | $8.8B | $8.7B | $6.0B | $6.3B |
| Income (loss) before taxes | $4.0B | $3.0B | $3.1B | ($1.2B) |
| Income tax benefit (expense) (Note 15) | ($396.3M) | ($32.6M) | $510.1M | $59.0M |
| Net income (loss) | $3.6B | $3.0B | $3.6B | ($1.2B) |
| Net (income) loss attributable to redeemable noncontrolling interests (Note 10) | ($935.4M) | ($1.1B) | ($1.1B) | $98.6M |
| Net income (loss) attributable to RenaissanceRe | $2.7B | $1.9B | $2.6B | ($1.1B) |
| Dividends on preference shares (Note 12) | -35.4M | -35.4M | -35.4M | -35.4M |
| Net income (loss) available (attributable) to RenaissanceRe common shareholders | $2.6B | $1.8B | $2.5B | ($1.1B) |
| Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share – basic (in dollars per share) | $56.23 | $35.31 | $52.40 | -$25.50 |
| Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share – diluted (in dollars per share) | $56.03 | $35.21 | $52.27 | -$25.50 |
| Line item | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 | Sep 30, 2025 · Q3 | Jun 30, 2025 · Q2 |
|---|---|---|---|---|
| Gross premiums written (Note 5) | $3.0B | $3.5B | $2.3B | $3.4B |
| Net premiums written (Note 5) | $2.3B | $2.7B | $2.1B | $2.8B |
| Decrease (increase) in unearned premiums | ($77.4M) | ($494.7M) | $376.0M | ($358.1M) |
| Net premiums earned (Note 5) | $2.2B | $2.2B | $2.4B | $2.4B |
| Net investment income (Note 3) | $432.5M | $420.5M | $438.4M | $413.1M |
| Net foreign exchange gains (losses) | ($7.3M) | ($9.0M) | $877.0K | $8.7M |
| Equity in earnings (losses) of other ventures | $17.8M | $20.5M | $12.6M | $20.3M |
| Other income (loss) | $4.5M | $1.2M | $705.0K | $2.6M |
| Net realized and unrealized gains (losses) on investments (Note 3) | $121.6M | ($421.9M) | $311.9M | $349.7M |
| Total revenues | $2.8B | $2.2B | $3.2B | $3.2B |
| Net claims and claim expenses incurred (Notes 5 and 6) | $942.4M | $984.0M | $878.8M | $1.0B |
| Acquisition expenses | $563.3M | $521.9M | $659.7M | $642.6M |
| Operational expenses | $94.7M | $89.0M | $125.1M | $125.7M |
| Corporate expenses | $18.7M | $19.5M | $23.4M | $23.8M |
| Interest expense (Note 7) | $31.8M | $31.8M | $30.6M | $31.8M |
| Total expenses | $1.7B | $1.6B | $1.7B | $1.9B |
| Income (loss) before taxes | $1.1B | $548.8M | $1.5B | $1.3B |
| Income tax benefit (expense) | ($139.4M) | ($33.0M) | ($148.9M) | ($176.9M) |
| Net income (loss) | $978.3M | $515.8M | $1.3B | $1.2B |
| Net (income) loss attributable to redeemable noncontrolling interests (Note 8) | ($315.3M) | ($222.5M) | ($415.2M) | ($328.3M) |
| Net income (loss) attributable to RenaissanceRe | $663.1M | $293.4M | $916.5M | $835.4M |
| Dividends on preference shares (Note 10) | -8.8M | -8.8M | -8.8M | -8.8M |
| Net income (loss) available (attributable) to RenaissanceRe common shareholders | $654.2M | $284.5M | $907.7M | $826.5M |
| Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share – basic (in dollars per share) | $15.54 | $6.60 | $19.47 | $17.25 |
| Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share – diluted (in dollars per share) | $15.48 | $6.57 | $19.40 | $17.20 |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Fixed maturity investments trading, at fair value - amortized cost $24,658,351 at December 31, 2025 (2024 - $23,750,540) (Notes 5 and 6) | $24.9B | $23.6B | $20.9B | $14.4B |
| Short term investments, at fair value - amortized cost $4,760,027 at December 31, 2025 (2024 - $4,532,166) (Notes 5 and 6) | $4.8B | $4.5B | $4.6B | $4.7B |
| Equity investments, at fair value (Notes 5 and 6) | $1.7B | $117.8M | $106.8M | $625.1M |
| Other investments, at fair value (Notes 5 and 6) | $4.6B | $4.3B | $3.5B | $2.5B |
| Investments in other ventures, under equity method (Note 5) | $121.9M | $102.8M | $112.6M | $79.8M |
| Total investments | $36.1B | $32.6B | $29.2B | $22.2B |
| Cash and cash equivalents | $1.7B | $1.7B | $1.9B | $1.2B |
| Premiums receivable (Note 7) | $7.3B | $7.3B | $7.3B | $5.1B |
| Prepaid reinsurance premiums | $993.8M | $888.3M | $924.8M | $1.0B |
| Reinsurance recoverable (Notes 7 and 8) | $3.9B | $4.5B | $5.3B | $4.7B |
| Accrued investment income | $233.7M | $238.3M | $205.7M | $121.5M |
| Deferred acquisition costs and value of business acquired | $1.5B | $1.6B | $1.8B | $1.2B |
| Deferred tax asset | $701.9M | $701.1M | $685.0M | — |
| Receivable for investments sold | $414.5M | $91.7M | $622.2M | $350.5M |
| Other assets | $328.1M | $444.0M | $324.0M | $384.7M |
| Goodwill and other intangible assets (Note 4) | $633.1M | $704.1M | $775.4M | $237.8M |
| Total assets | $53.8B | $50.7B | $49.0B | $36.6B |
| Reserve for claims and claim expenses (Note 8) | $22.3B | $21.3B | $20.5B | $15.9B |
| Unearned premiums | $6.0B | $6.0B | $6.1B | $4.6B |
| Debt (Note 9) | $2.3B | $1.9B | $2.0B | $1.2B |
| Reinsurance balances payable | $2.5B | $2.8B | $3.2B | $3.9B |
| Payable for investments purchased | $533.1M | $150.7M | $661.6M | $493.8M |
| Other liabilities | $856.3M | $1.1B | $1.0B | $648.0M |
| Total liabilities | $34.6B | $33.2B | $33.5B | $26.7B |
| Redeemable noncontrolling interests (Note 10) | $7.6B | $7.0B | $6.1B | $4.5B |
| Preference shares: $1.00 par value – 30,000 shares issued and outstanding at December 31, 2025 (2024 – 30,000) (Note 12) | 750.0M | 750.0M | 750.0M | 750.0M |
| Common shares: $1.00 par value – 43,961,539 shares issued and outstanding at December 31, 2025 (2024 – 50,180,987) (Note 12) | 44.0M | 50.2M | 52.7M | 43.7M |
| Additional paid-in capital (Note 12) | $0 | $1.5B | $2.1B | $475.6M |
| Accumulated other comprehensive income (loss) | ($12.6M) | ($14.8M) | ($14.2M) | ($15.5M) |
| Retained earnings (Note 12) | $10.8B | $8.3B | $6.5B | $4.1B |
| Total shareholders’ equity attributable to RenaissanceRe | $11.6B | $10.6B | $9.5B | $5.3B |
| Total liabilities, noncontrolling interests and shareholders’ equity | $53.8B | $50.7B | $49.0B | $36.6B |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 |
|---|---|---|---|---|
| Fixed maturity investments trading, at fair value - amortized cost $25,281,536 at June 30, 2026 (December 31, 2025 - $24,658,351) (Notes 3 and 4) | $25.2B | $24.9B | $23.8B | $23.3B |
| Short term investments, at fair value - amortized cost $3,952,780 at June 30, 2026 (December 31, 2025 - $4,760,027) (Notes 3 and 4) | $3.9B | $3.9B | $6.0B | $5.7B |
| Equity investments, at fair value (Notes 3 and 4) | $1.8B | $1.6B | $1.5B | $912.4M |
| Other investments, at fair value (Notes 3 and 4) | $5.1B | $4.7B | $4.4B | $4.5B |
| Investments in other ventures, under equity method | $149.3M | $140.9M | $115.6M | $112.6M |
| Total investments | $36.2B | $35.2B | $35.8B | $34.5B |
| Cash and cash equivalents | $1.3B | $1.6B | $1.7B | $1.4B |
| Premiums receivable (Note 5) | $8.3B | $8.1B | $8.1B | $9.1B |
| Prepaid reinsurance premiums | $1.6B | $1.4B | $1.2B | $1.4B |
| Reinsurance recoverable (Notes 5 and 6) | $3.9B | $3.7B | $4.1B | $4.3B |
| Accrued investment income | $250.6M | $234.7M | $225.3M | $228.8M |
| Deferred acquisition costs and value of business acquired | $1.7B | $1.7B | $1.7B | $1.7B |
| Deferred tax asset | $693.2M | $705.7M | $705.5M | $699.7M |
| Receivable for investments sold | $305.2M | $182.5M | $54.6M | $281.1M |
| Other assets | $422.1M | $393.9M | $267.3M | $369.6M |
| Goodwill and other intangible assets | $602.4M | $617.8M | $651.3M | $668.8M |
| Total assets | $55.2B | $53.7B | $54.5B | $54.7B |
| Reserve for claims and claim expenses (Note 6) | $22.3B | $22.3B | $22.7B | $22.9B |
| Unearned premiums | $7.2B | $6.9B | $7.0B | $7.6B |
| Debt (Note 7) | $2.3B | $2.3B | $2.2B | $2.3B |
| Reinsurance balances payable | $3.1B | $2.8B | $2.7B | $3.0B |
| Payable for investments purchased | $550.4M | $308.6M | $298.9M | $492.1M |
| Other liabilities | $649.6M | $523.9M | $596.0M | $606.4M |
| Total liabilities | $36.0B | $35.2B | $35.5B | $36.9B |
| Redeemable noncontrolling interests (Note 8) | $7.3B | $7.0B | $7.5B | $7.0B |
| Preference shares: $1.00 par value - 30,000 shares issued and outstanding at June 30, 2026 (December 31, 2025 - 30,000) (Note 10) | 750.0M | 750.0M | 750.0M | 750.0M |
| Common shares: $1.00 par value - 41,811,353 shares issued and outstanding at June 30, 2026 (December 31, 2025 - 43,961,539) (Note 10) | 41.8M | 43.0M | 46.5M | 47.4M |
| Additional paid-in capital (Note 10) | $0 | $0 | $605.3M | $791.0M |
| Accumulated other comprehensive income (loss) | ($13.0M) | ($12.2M) | ($13.6M) | ($13.8M) |
| Retained earnings (Note 10) | $11.0B | $10.7B | $10.1B | $9.2B |
| Total shareholders’ equity attributable to RenaissanceRe | $11.8B | $11.5B | $11.5B | $10.8B |
| Total liabilities, noncontrolling interests and shareholders’ equity | $55.2B | $53.7B | $54.5B | $54.7B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net income (loss) | $3.6B | $3.0B | $3.6B | ($1.2B) |
| Amortization, accretion and depreciation | ($14.1M) | $258.5M | ($134.8M) | ($26.9M) |
| Equity in undistributed (earnings) losses of other ventures | ($17.2M) | $9.0M | ($7.6M) | $10.7M |
| Net realized and unrealized (gains) losses on investments | ($1.2B) | ($29.4M) | ($482.8M) | $1.6B |
| Premiums receivable | $37.8M | ($9.5M) | ($126.9M) | ($1.4B) |
| Prepaid reinsurance premiums | ($105.4M) | $36.4M | $223.4M | ($166.7M) |
| Reinsurance recoverable | $581.5M | $862.9M | $663.9M | ($442.3M) |
| Deferred acquisition costs and value of business acquired | $13.8M | $199.1M | $37.3M | ($322.6M) |
| Reserve for claims and claim expenses | $998.9M | $816.6M | ($34.7M) | $2.6B |
| Unearned premiums | $77.8M | ($185.7M) | ($227.0M) | $1.0B |
| Reinsurance balances payable | ($263.8M) | ($381.8M) | ($1.0B) | $67.3M |
| Other | ($51.7M) | ($371.7M) | ($579.3M) | ($259.2M) |
| Net cash provided by (used in) operating activities | $3.7B | $4.2B | $1.9B | $1.6B |
| Proceeds from sales and maturities of fixed maturity investments trading | $12.7B | $23.5B | $21.8B | $22.1B |
| Purchases of fixed maturity investments trading | ($13.3B) | ($26.3B) | ($24.8B) | ($24.9B) |
| Proceeds from sales of short term investments | $45.6B | $31.8B | — | — |
| Purchases of short term investments | ($45.7B) | ($31.6B) | — | — |
| Proceeds from sales of equity investments | $1.6M | $463.0K | — | — |
| Purchases of equity investments | ($1.6B) | ($205.0K) | — | — |
| Proceeds from sales of other investments | $1.0B | $1.1B | — | — |
| Purchases of other investments | ($1.5B) | ($1.5B) | — | — |
| Purchases of investments in other ventures | ($1.1M) | ($57.3M) | ($25.3M) | ($773.0K) |
| Return of investments in other ventures | $321.0K | $41.3M | $5.6M | $2.2M |
| Net settlements of derivatives | $564.3M | — | — | — |
| Net purchase of Validus | $0 | $0 | ($2.4B) | — |
| Net cash provided by (used in) investing activities | ($2.2B) | ($3.1B) | ($3.8B) | ($3.0B) |
| Dividends paid – RenaissanceRe common shares | -74.8M | -80.8M | -75.1M | -64.7M |
| Dividends paid – preference shares | -35.4M | -35.4M | -35.4M | -35.4M |
| RenaissanceRe common share repurchases | ($1.6B) | ($666.9M) | $0 | ($166.7M) |
| RenaissanceRe common share issuance, net of expenses | $0 | $0 | $1.4B | $0 |
| Repayment of debt | ($450.0M) | — | — | $0 |
| Issuance of debt, net of expenses | $889.1M | $0 | $740.6M | — |
| Repayment of Medici Revolving Credit Facility | ($75.0M) | ($150.0M) | ($30.0M) | — |
| Drawdown of Medici Revolving Credit Facility | $75.0M | $75.0M | $75.0M | $0 |
| Subscriptions of third-party redeemable noncontrolling interest shares | 212.2M | 537.4M | — | — |
| Redemptions of third-party redeemable noncontrolling interest shares | -328.4M | -943.2M | — | — |
| Taxes paid on withholding shares | -23.5M | -23.6M | -20.5M | -10.9M |
| Net cash provided by (used in) financing activities | ($1.4B) | ($1.3B) | $2.6B | $725.3M |
| Effect of exchange rate changes on foreign currency cash | ($12.2M) | ($17.4M) | $5.5M | $22.5M |
| Net increase (decrease) in cash and cash equivalents | $54.6M | ($200.9M) | $683.2M | ($664.7M) |
| Cash and cash equivalents, beginning of year | $1.7B | $1.9B | $1.2B | $1.9B |
| Cash and cash equivalents, end of year | $1.7B | $1.7B | $1.9B | $1.2B |
| Interest paid | $111.8M | $88.0M | $73.5M | $46.2M |
| Non-cash consideration | $0 | $0 | $285.2M | — |
| Line item | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 | Sep 30, 2025 · YTD | Jun 30, 2025 · YTD |
|---|---|---|---|---|
| Net income (loss) | $1.5B | $515.8M | $2.5B | $1.1B |
| Amortization, accretion and depreciation | ($47.6M) | ($24.4M) | $2.4M | $9.2M |
| Equity in undistributed (earnings) losses of other ventures | ($5.5M) | ($1.9M) | ($11.2M) | ($8.6M) |
| Net realized and unrealized (gains) losses on investments | $300.3M | $421.9M | ($496.6M) | ($365.7M) |
| Premiums receivable | ($1.0B) | ($845.4M) | ($840.3M) | ($1.8B) |
| Prepaid reinsurance premiums | ($574.0M) | ($361.1M) | ($328.4M) | ($527.3M) |
| Reinsurance recoverable | $36.4M | $169.0M | $396.3M | $180.4M |
| Deferred acquisition costs and value of business acquired | ($167.6M) | ($127.1M) | ($103.7M) | ($179.9M) |
| Reserve for claims and claim expenses | ($33.2M) | ($11.3M) | $1.4B | $1.6B |
| Unearned premiums | $1.1B | $857.3M | $1.0B | $1.6B |
| Reinsurance balances payable | $515.5M | $281.4M | ($101.3M) | $243.6M |
| Other | ($109.5M) | ($186.6M) | ($222.9M) | ($268.4M) |
| Net cash provided by (used in) operating activities | $1.5B | $687.6M | $3.2B | $1.6B |
| Proceeds from sales and maturities of fixed maturity investments trading | $9.5B | $3.7B | $10.8B | $7.0B |
| Purchases of fixed maturity investments trading | ($10.0B) | ($3.9B) | ($10.3B) | ($6.2B) |
| Proceeds from sales of short term investments | $25.3B | $12.8B | $30.7B | $17.3B |
| Purchases of short term investments | ($24.5B) | ($11.9B) | ($32.1B) | ($18.4B) |
| Proceeds from sales of equity investments | $472.5M | $472.6M | $1.2M | $601.0K |
| Purchases of equity investments | ($647.4M) | ($408.4M) | ($1.3B) | ($766.6M) |
| Proceeds from sales of other investments | $691.6M | $288.8M | $803.4M | $619.1M |
| Purchases of other investments | ($1.1B) | ($423.6M) | ($942.0M) | ($859.7M) |
| Purchases of investments in other ventures | ($24.8M) | ($17.8M) | ($1.0M) | ($565.0K) |
| Return of investments in other ventures | $2.4M | $571.0K | $248.0K | $203.0K |
| Net settlements of derivatives | $37.1M | ($123.5M) | — | — |
| Net cash provided by (used in) investing activities | ($211.2M) | $471.1M | ($2.3B) | ($1.3B) |
| Dividends paid – common shares | -34.5M | -17.6M | -57.3M | -38.7M |
| Dividends paid – preference shares | -17.7M | -8.8M | -26.5M | -17.7M |
| RenaissanceRe common share repurchases | ($702.5M) | ($352.0M) | ($939.6M) | ($731.4M) |
| Repayment of debt | $0 | — | ($450.0M) | ($450.0M) |
| Issuance of debt, net of expenses | $0 | $0 | $789.9M | $790.0M |
| Repayment of Medici Revolving Credit Facility | $0 | — | ($75.0M) | ($40.0M) |
| Drawdown of Medici Revolving Credit Facility | $0 | $0 | $75.0M | $75.0M |
| Subscriptions of third-party redeemable noncontrolling interest shares | 4.5M | 3.0M | 121.6M | 103.8M |
| Redemptions of third-party redeemable noncontrolling interest shares | -965.5M | -915.8M | -304.7M | -296.6M |
| Taxes paid on withholding shares | -27.2M | -27.1M | -21.6M | -21.5M |
| Net cash provided by (used in) financing activities | ($1.7B) | ($1.3B) | ($888.2M) | ($627.1M) |
| Effect of exchange rate changes on foreign currency cash | ($14.9M) | ($8.7M) | $3.4M | $2.4M |
| Net increase (decrease) in cash and cash equivalents | ($429.0M) | ($168.3M) | $25.0M | ($247.9M) |
| Cash and cash equivalents, beginning of period | $1.7B | $1.7B | $1.7B | $1.7B |
| Cash and cash equivalents, end of period | $1.3B | $1.6B | $1.7B | $1.4B |
RENAISSANCERE HOLDINGS LTD score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.